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Abstract
The use of iodine contrast, which is more commonly used, is associated with systemic effects in nephrogenic systemic fibrosis, contrast-induced nephropathy (CIN) in
patients with kidney function disorders, geriatric, hypertension, and patients with comorbid diabetes mellitus and hypersensitivity reactions. An evidence-based case
report was carried out in the Medical Department of Surgery, FKUI-RSCM. The study indicated that the safety of CO2 angiography did not cause CIN to manifest and
showing CO2 contrast proved to be safe for patients who have impaired renal function.
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Introduction
The use of CO2 contrast in angiography has been known since 1950.
However, In the 1970s, intraarterial CO2 contrast was reported with a
sustained progress in the development of digital subtraction angiography
(DSA) that gave good results as a supporting tool for endovascular
procedures. Meanwhile, the use of iodine contrast, which is more
commonly used, is associated with systemic effects in nephrogenic
systemic fibrosis, contrast-induced nephropathy in patients with renal
dysfunction, geriatric, hypertension, and patients with comorbid
diabetes mellitus and hypersensitivity. For this reason, it is necessary to
find a level of evidence supporting studies and literature that supports the
use of CO2 as a contrast agent in a multi comorbid patient with a display
quality that is not significantly different from iodine contrast in patients
undergoing angiography procedures.
Case illustration
A 73-year-old man came to the ER with a chief complaint of intermittent
abdominal pain for three days. The pain felt pulsated, did not radiate, and
presented inconsistently for the last two months, but no changes in bowel
habits. The patient once came to dr. Cipto Mangunkusumo
Hospital Emergency Room (ER) in the previous two months with
constipation and a colic abdominal pain, and the diagnostic examination
show an obstruction on the bowel. Afterward, the patient underwent
explorative laparotomy. Intraoperatively mild adhesion of the bowel
was found, which was released. Another critical finding was pulsating
abdominal aorta. Computed Topography Angiography (CTA) was
done and shows an abdominal infrarenal aorta aneurysm about 41 mm
from the left renal artery to aorta bifurcation with a diameter of 47 mm,
then the patient was scheduled for Endovascular Aneurysm Repair
(EVAR). On further history taking, we found hypertension for a year.
The hemodynamic was stable with blood pressure was 120/70 mmHg,
heart rate was 88 bpm, and oxygen saturation was 99%. The abdomen
was flat with a normal bowel movement. There was no tenderness and

no palpable mass, but we found a pulsatile area in the
supraumbilical. Before surgery, the haemoglobin content was 10g/dL,
urea 45.8 mg/dL, creatinine serum was 2.23 mg/dL. Blood gas analysis
denoting pH 7.5, pCO2 31.8 mmHg, pO2 262.2mmHg, base excess 3.9
mmol/L, HCO3 -25.8 mmol/L.
Angiography with CO2 contrast using a CO2 injector with bilateral
femoral access has been inserted beforehand. We did diagnostic tests
with CO2 with the volume of 100 ml and a 700 mmHg pressure.
Radiographic imaging with DSA 3-6 frames per second post CO2
injection. After EVAR, the blood pressure was 110/70, the heart rate was
70 bpm, and the saturation was 99%. The abdomen was flat, normal
bowel movement, tympanic on percussion, no hematoma on the
puncture site. VAS score of 1-2, no vomiting. The hemoglobin content
10.8 g/dL, pCO2 34.5 mmHg, pO2 258.1 mmHg, base excess 3.2
mmol/L, HCO 3 -25.9 mmol/L. The urea 28 mg/dL and creatinine
serum 1.6 mg/dL.
We proceed a literature search to answer the clinical questions, namely
a level of evidence of the procedure. The keywords used were "renal
insufficiency" or "kidney failure" AND "angiography CO2" OR "CO2
angiography" AND "iodine contrast" OR "iodinated contrast" AND
"contrast-induced nephropathy" OR "CIN" in some databases, i.e.,
Cochrane Library, PubMed and ScienceDirect. Three articles supported
our case reports, a prospective study, and two retrospective cohort
studies with a level of evidence 3. me databases, i.e., Cochrane Library,
PubMed and ScienceDirect. Three articles supported our case reports, a
prospective study, and two retrospective cohort studies with a level of
evidence 3. The studies indicated the safety of the use of CO2
angiography, and no one manifested to contrast-induced nephropathy.
Discussion
We found three articles to support our case on literature search and
discussed CO2 contrast as an alternative for patients with renal
impairment. Fujihara et al. have done the angiography and angioplasty
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for the iliofemoral abnormality using CO2 contrast and a combination, if
necessary, with a minimal dose. The incidence of contrast-induced
nephropathy was approximately 5.1% of all cases.
Spinosa et al. reported that an increased creatinine serum incidence was
higher when CO2 is combined with Gadodiamide compared with
noniodine contrast. Zero incidences of contrast-induced nephropathy
were found with the use of CO2 alone. Scalise et al. comparing the
visibility of 40 patients with CO2 compared with iodine iodixanol
showed no significant difference. Approximately 94 to 98 percent have
reported no incidence of contrast-induced nephropathy. Chao's study
enrolling 100 patients who underwent EVAR found that creatinine
serum was normal in half of their samples. The group with increased
creatinine serum was those given CO2 contrast.
In the 30 days follow-up, they reported no incidence of contrast-induced
nephropathy in the two groups (those given CO2 contrast and those not);
but they found the difference regarding endoleak. In the group, which
was given CO2 contrast, 18% of them occurred but not statistically
significant. Radiation dose is not increased to the patient who treated
using CO2.

Conclusion
The use of CO2 contrast is safe for patients with impaired renal function.
The incidence of contrast-induced nephropathy was considered minimal
and, in some studies, was not found.
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